Succinyl phosphonate
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Succinyl phosphonate
Description :
Succinyl phosphonate is an α-ketoglutarate dehydrogenase (KGDHC) inhibitor, effective inhibits (KGDHC) in muscle, bacterial, brain, and cultured human fibroblasts[1][4]. Succinyl phosphonate trisodium salt is an 2-oxoglutarate dehydrogenase (OGDH) inhibitor, impairs viability of cancer cells in a cell-specific metabolism-dependent manner[2]. Succinyl phosphonate trisodium salt inhibits the glutamate-induced ROS production in glutamate-stimulated hippocampal neurons in situ[3].UNSPSC :
12352211Hazard Statement :
H302, H312, H332Target :
Endogenous Metabolite; Reactive Oxygen Species (ROS)Type :
Reference compoundRelated Pathways :
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κBField of Research :
Neurological DiseaseAssay Protocol :
https://www.medchemexpress.com/Succinyl-phosphonate.htmlPurity :
98.0Solubility :
10 mM in DMSOSmiles :
O=C(O)CCC(P(O)(O)=O)=OMolecular Formula :
C4H7O6PMolecular Weight :
182.07Precautions :
H302, H312, H332References & Citations :
[1]Biryukov AI, et al. Succinyl phosphonate inhibits alpha-ketoglutarate oxidative decarboxylation, catalyzed by alpha-ketoglutarate dehydrogenase complexes from E. coli and pigeon breast muscle. FEBS Lett. 1996 Mar 11;382 (1-2) :167-70.|[2]Bunik VI, et al. Phosphonate analogues of alpha-ketoglutarate inhibit the activity of the alpha-ketoglutaratedehydrogenase complex isolated from brain and in cultured cells. Biochemistry. 2005 Aug 9;44 (31) :10552-61.|[3]Zündorf G, et al. alpha-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ. Neuroscience. 2009 Jan 23;158 (2) :610-6.|[4]Bunik VI, et al. Phosphonate analogues of alpha-ketoglutarate inhibit the activity of the alpha-ketoglutarate dehydrogenase complex isolated from brain and in cultured cells. Biochemistry. 2005 Aug 9;44 (31) :10552-61.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedCitation 01 :
ACS Chem Biol. 2020 Aug 21;15 (8) :2041-2047.|Cancer Res. 2019 Jul 1;79 (13) :3281-3293. |Cell Death Dis. 2021 Oct 25;12 (11) :999.|Exp Cell Res. 2019 Sep 15;382 (2) :111483.|Free Radic Biol Med. 2016 Jul:96:22-33.|Plant Signal Behav. 2019;14 (7) :1604015.|Planta. 2018 Oct;248 (4) :963-979.|Redox Biol. 2023 Jun:62:102669.|bioRxiv. 2024 Jan 15.|Clin Rheumatol. 2025 Nov 20.|Research Square Preprint. 2022.|Research Square Print. 2022 May.CAS Number :
[26647-82-5]

